Fuller R W, Vallance P J
Br J Clin Pharmacol. 1982 Sep;14(3):445-6. doi: 10.1111/j.1365-2125.1982.tb02005.x.
In a double-blind placebo controlled cross-over trial involving six subjects, atenolol, taken by mouth for 3 days, caused a statistically significant reduction in blood pressure and FEV.
在一项涉及6名受试者的双盲安慰剂对照交叉试验中,口服阿替洛尔3天可使血压和第一秒用力呼气量出现具有统计学意义的下降。